Australia · Delayed Price · Currency is AUD Artrya Statistics
Total Valuation
Artrya has a market cap or net worth of AUD 738.23 million. The enterprise value is 664.45 million.
| Market Cap | 738.23M |
| Enterprise Value | 664.45M |
Important Dates
The next estimated earnings date is Tuesday, November 24, 2026.
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Artrya has 162.96 million shares outstanding. The number of shares has increased by 60.73% in one year.
| Current Share Class | 162.96M |
| Shares Outstanding | 162.96M |
| Shares Change (YoY) | +60.73% |
| Shares Change (QoQ) | +22.04% |
| Owned by Insiders (%) | 13.55% |
| Owned by Institutions (%) | 22.82% |
| Float | 110.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26,365.18 |
| PB Ratio | 9.43 |
| P/TBV Ratio | 10.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.72, with a Debt / Equity ratio of 0.00.
| Current Ratio | 15.72 |
| Quick Ratio | 15.64 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -1,724.50 |
Financial Efficiency
Return on equity (ROE) is -50.58% and return on invested capital (ROIC) is -34.33%.
| Return on Equity (ROE) | -50.58% |
| Return on Assets (ROA) | -31.63% |
| Return on Invested Capital (ROIC) | -34.33% |
| Return on Capital Employed (ROCE) | -34.37% |
| Weighted Average Cost of Capital (WACC) | 7.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Artrya has paid 1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.50% in the last 52 weeks. The beta is 0.59, so Artrya's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +125.50% |
| 50-Day Moving Average | 5.13 |
| 200-Day Moving Average | 4.18 |
| Relative Strength Index (RSI) | 43.56 |
| Average Volume (20 Days) | 830,149 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Artrya had revenue of AUD 28,000 and -25.18 million in losses. Loss per share was -0.17.
| Revenue | 28,000 |
| Gross Profit | -20.02M |
| Operating Income | -27.59M |
| Pretax Income | -25.18M |
| Net Income | -25.18M |
| EBITDA | -27.13M |
| EBIT | -27.59M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 74.03 million in cash and 247,000 in debt, with a net cash position of 73.78 million or 0.45 per share.
| Cash & Cash Equivalents | 74.03M |
| Total Debt | 247,000 |
| Net Cash | 73.78M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 78.29M |
| Book Value Per Share | 0.48 |
| Working Capital | 74.70M |
Cash Flow
In the last 12 months, operating cash flow was -17.96 million and capital expenditures -140,000, giving a free cash flow of -18.10 million.
| Operating Cash Flow | -17.96M |
| Capital Expenditures | -140,000 |
| Depreciation & Amortization | 1.26M |
| Net Borrowing | -351,000 |
| Free Cash Flow | -18.10M |
| FCF Per Share | -0.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | -98,542.86% |
| Pretax Margin | -89,935.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Artrya does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.73% |
| Shareholder Yield | -60.73% |
| Earnings Yield | -3.41% |
| FCF Yield | -2.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Artrya is 6.24, which is 38.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 6.24 |
| Price Target Difference | 38.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 114.16% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Artrya has an Altman Z-Score of 41.03 and a Piotroski F-Score of 1.
| Altman Z-Score | 41.03 |
| Piotroski F-Score | 1 |